Researchers Find Existing Medications That Could Speed Recovery of COVID-19 Patients
Researchers who combed through a “library” of previously approved drugs believe they have identified a medication with the potential to help speed a COVID-19 patient’s recovery from SARS-CoV-2 infection. More...19 Oct 2020
Gilead’s Remdesivir Has Little or No Effect on Survival of COVID-19 Patients, Finds WHO’s Solidarity Trial
The world’s largest randomized control trial on COVID-19 therapeutics has found that Gilead Sciences’ (Foster City, CA, USA) antiviral drug remdesivir had no significant effect on the chances of survival of infected patients. More...19 Oct 2020
COVID-19 Antibody Cocktail Won’t Be Widely Available Due to Limited Production Capacity, Says Roche
The experimental antibody drug cocktail being developed for the treatment of COVID-19 is unlikely to become widely available as it would be impossible to make enough for everyone who needed it, according to Bill Anderson, drugs chief at Roche Holding AG (Basel, Switzerland). More...19 Oct 2020
SARS-CoV-2 Neutralizing Antibodies Fade Quickly in Recovering COVID-19 Patients After Symptoms Subside
SARS-CoV-2 antibody levels in the blood of COVID-19 patients decline rapidly during the weeks after their bodies have cleared the virus and symptoms have subsided, according to a new study. More...19 Oct 2020
World’s Simplest High-Throughput RT-PCR Test for COVID-19 Could Increase Testing Capacity by Millions per Week
An extraction-free, direct sample addition RT-PCR test for the detection of SARS-CoV-2 viral RNA in patients suspected of COVID-19 has the potential to increase testing capacity by millions per week. More...19 Oct 2020
At Least One Effective COVID-19 Vaccine to Be Available by 2021, But Only in Limited Quantities, Says WHO
There would be at least one safe and effective COVID-19 vaccine by 2021, although it will be available in “limited quantities” which may require priority to be given to vulnerable people and result in a delay in the immunization of healthy, young people until 2022. More...16 Oct 2020
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
New
Mobile Power Procedure Chair
LeMans P360
New
In-Bed Scale
IBFL500
In Other News
Extremely Rapid COVID-19 Diagnostic Test Detects and Identifies SARS-CoV-2 Virus in Under Five Minutes
New 1-Minute COVID-19 Antibody Test Uses Innovative Flow-Through Technology to Deliver Results
Siemens Launches New Rapid COVID-19 Antigen Test for Detection of SARS-CoV-2
New COVID-19 Test Uses Nanotube-Based Electrochemical Biosensor for Rapid Detection of SARS-CoV-2 Virus in 30 Seconds
COVID-19 Vaccine May Not Need to Achieve Highest Possible RBD-S Antibody Levels, Say Researchers
World's First Paper-Based COVID-19 Test Could Be Game-Changer for Coronavirus Testing
Eli Lilly Pauses Trial of Combination Antibody Treatment for COVID-19 Due to Safety Concerns
Study by Scientists Who Discovered SARS Could Lead to Development of COVID-19 Treatment Inspired by Own Immune System (B)
Unique COVID-19 Vaccine Uses Modified Bovine Adenovirus to Provide Significantly Higher Levels of Immunity (B)
Intranasal COVID-19 Vaccine Candidate Shows Potent Immune Responses in Extensive Preclinical Tests
Roche to Launch Elecsys SARS-CoV-2 Antigen Test for High-Volume COVID-19 Testing
Blocking Immune System Pathway Could Stop COVID-19 Infection, Finds Study
Nanopore Sequencing and Machine Learning Powered-Platform Enables High-Accuracy, High-Frequency COVID-19 Testing
Cryo-Electron Microscopy Reveals SARS-CoV-2 Surface Adopts 10 Different Structural States upon Contact with ACE2
Peel-and-Sniff Cards Could Make Smell Test Single Best Predictor of Being COVID-19 Positive
Production of High-Quality Antibodies Continues 5-7 Months After SARS-CoV-2 Infection, Finds New Study
Glucose Monitor for Measuring Blood Sugar Levels Reconfigured for Use as SARS-CoV-2 Antibody Detector
Holographic Imaging-Based COVID-19 Test Could Detect Both SARS-CoV-2 Infection and Antibodies in 30 Minutes
Johnson & Johnson COVID-19 Vaccine Trials Temporarily Paused Due to Unexplained Illness in Participant
COVID-19 Vaccine Could Have 80-90% Efficacy and Secure FDA EUA by Late November, Says Head of Operation Warp Speed
Regeneron's Antibody Cocktail Could Be Used to Treat as Well as Prevent COVID-19, Finds Study
Abbott COVID-19 IgM Antibody Blood Test Granted FDA Emergency Use Authorization
30-Second COVID-19 Breathalyzer Test Could Be a Game-Changer
